2018
DOI: 10.1111/liv.13730
|View full text |Cite
|
Sign up to set email alerts
|

Osteoporosis in chronic liver disease

Abstract: Osteoporosis is a frequent complication in patients with chronic liver disease, especially in end-stages and in chronic cholestasis, in addition to non-alcoholic fatty liver disease, haemochromatosis and alcoholism. Mechanisms underlying osteoporosis are poorly understood, but osteoporosis mainly results from low bone formation. In this setting, sclerostin, a key regulator of the Wnt/β-catenin signalling pathway which regulates bone formation, in addition to the effects of the retained substances of cholestasi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
93
1
4

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 87 publications
(99 citation statements)
references
References 113 publications
(233 reference statements)
1
93
1
4
Order By: Relevance
“…Although our meta‐analysis did not show any significant and consistent difference in BMD at various skeletal sites according to NAFLD severity, it is known that osteoporosis is a frequent complication in patients with cirrhosis, especially in those with alcoholic cirrhosis or advanced cholestatic liver disease . In this clinical setting, the main risk factors are disease severity, older age and duration of cholestasis.…”
Section: Discussioncontrasting
confidence: 58%
See 2 more Smart Citations
“…Although our meta‐analysis did not show any significant and consistent difference in BMD at various skeletal sites according to NAFLD severity, it is known that osteoporosis is a frequent complication in patients with cirrhosis, especially in those with alcoholic cirrhosis or advanced cholestatic liver disease . In this clinical setting, the main risk factors are disease severity, older age and duration of cholestasis.…”
Section: Discussioncontrasting
confidence: 58%
“…In this clinical setting, the main risk factors are disease severity, older age and duration of cholestasis. Abnormalities in endocrine system and homeostasis, such as hypogonadism and vitamin D 3 deficiency, as well as malnutrition and drug‐induced effects, may also be involved in osteoporosis development among cirrhotic patients . Less is currently known about the presence of bone and mineral disorders in NAFLD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The finding of a significant, graded relationship between the histological severity of NAFLD and whole‐body BMD Z scores is particularly relevant in view of the disease burden that NAFLD represents and the potential impact on health care resources needed to survey and manage these patients adequately. It is known that osteoporosis and osteomalacia are two frequent complications in adult patients with cirrhosis, especially in those with alcoholic cirrhosis or advanced cholestatic liver disease . However, because our results are only based on four cross‐sectional studies (involving a total of 184 overweight/obese adolescents with biopsy‐proven NASH or no‐NASH), we believe that this question remains currently unresolved, and further larger studies are needed in order to prove whether the histological severity of NAFLD adversely affects bone health in childhood.…”
Section: Discussionmentioning
confidence: 94%
“…It is known that osteoporosis and osteomalacia are two frequent complications in adult patients with cirrhosis, especially in those with alcoholic cirrhosis or advanced cholestatic liver disease. (29,30) However, because our results are only based on four cross-sectional studies (involving a total of 184 overweight/obese adolescents with biopsy-proven NASH or no-NASH), we believe that this question remains currently unresolved, and further larger studies are needed in order to prove whether the histological severity of NAFLD adversely affects bone health in childhood.…”
Section: Discussionmentioning
confidence: 98%